Global Cost-Effectiveness of Cardiac Resynchronization Therapy for Heart Failure

A systematic review document summarizing evidence on the cost-effectiveness of cardiac resynchronization therapy (CRT) for heart failure. The review includes 18 studies published between 2004 and 2025, with costs converted to 2024 euros. It was authored by Kaltrina Bajraktari and last updated in May 2026.

Use Cases

• Benchmarking cost-effectiveness ratios (ICERs) for CRT against country-specific willingness-to-pay thresholds.
• Comparing the economic outcomes of CRT-P versus CRT-D device types based on the reviewed evidence.
• Supporting health technology assessment (HTA) submissions for CRT devices using aggregated QALY and ICER data.

Strengths

• Includes a specific number of studies (18) meeting inclusion criteria.
• Costs were standardized to a single currency and year (2024 euros) for comparison.
• The review is registered with a PROSPERO ID (CRD420251171292), indicating a structured methodology.

Limitations

• The dataset is a 17.4 KB DOCX file, indicating a very limited scope, likely a summary table or document.
• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment for quantitative analysis.

Provenance

Source

figshare, author Kaltrina Bajraktari

Collection Method

Systematic review of Web of Science, PubMed, and Scopus from January 2004 to July 2025.

Time Range

Studies published from 2004 to 2025.

Freshness

Last updated 2026-05-21 12:55:05

Geography

Global (multiple healthcare settings)